मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष

कोशिश गोल्ड - मुक्त

New hope for migraine

Financial Express Hyderabad

|

April 06, 2025

Know about a new drug & if it is for you

- Dr PN Renjen

MIGRAINE CAN BE debilitating. However, a new drug, atogepant, which is taken orally, promises efficacy for the condition. But how effective is it? Dr PN Renjen, senior consultant, neurology, Indraprastha Apollo Hospitals, says: "Atogepant is a promising oral medication for the preventive treatment of migraines. It is a calcitonin gene-related peptide (CGRP) receptor antagonist, specifically designed to reduce the frequency of migraine days. Clinical trials, such as the advance and elevate studies, demonstrated significant efficacy in reducing monthly migraine days (MMDs) and improving functional outcomes within just weeks of treatment. In particular, atogepant showed early benefits, with reductions in weekly migraine days and improved quality-of-life measures during the first month of use. It is effective for both episodic and chronic migraines

Financial Express Hyderabad से और कहानियाँ

Financial Express Hyderabad

No flight cancellations after Feb 10: IndiGo to regulator

ON THE RADAR

time to read

1 min

January 21, 2026

Financial Express Hyderabad

Re below 91 for first time in 2026

Declines 6 paise to close at 90.98 versus dollar

time to read

2 mins

January 21, 2026

Financial Express Hyderabad

India among top investment hubs

13% of global CEOs prefer higher investments in country: PwC survey

time to read

1 min

January 21, 2026

Financial Express Hyderabad

Al anxiety grips millennials, Gen Z

AS AI TRANSFORMS workplaces, a Randstad survey says employers are optimistic but Gen Z is anxious, fearing automation will reward firms more than workers

time to read

1 min

January 21, 2026

Financial Express Hyderabad

IT majors’ deal wins signal stability in tech spending

DEAL WINS REPORTED by the country’s top four IT services companies in the December quarter point to early signs of stabilisation in client spending, even as revenue growth remains subdued and recovery uneven across players.

time to read

2 mins

January 21, 2026

Financial Express Hyderabad

Markets log worst day in 8 months on weak earnings

INVESTOR WEALTH ERODES ALMOST ₹10 LAKH CRORE

time to read

1 min

January 21, 2026

Financial Express Hyderabad

200% tariff threat looms over French wines

Wine tariff threat part of broader salco against EU

time to read

1 min

January 21, 2026

Financial Express Hyderabad

TaMo to bid for 6K e-buses, but rules out any price war

TATA MOTORS WILL participate in the government’s upcoming tender for around 6,000 electric buses but will avoid aggressive bidding, opting instead for a cautious and financially disciplined approach, Managing Director and Chief Executive Officer Girish Wagh told FE.

time to read

1 mins

January 21, 2026

Financial Express Hyderabad

Banks to seek RBI’s approval for longer bulk deposits

BANKS WILL APPROACH the Reserve Bank of India (RBI) for approval to raise bulk deposits for up to three years compared to the current one year cap, three sources said on Tuesday.

time to read

1 min

January 21, 2026

Financial Express Hyderabad

Consumption, imports of fertilisers surge; domestic output drops

WHILE THE GOVERNMENT is aiming to cut urea and diammonium phosphate (DAP) consumption through introduction of nano-variants, sales and imports of varieties of fertilisers have surged significantly, trade sources said.

time to read

2 mins

January 21, 2026

Listen

Translate

Share

-
+

Change font size